---
schema_version: "secwatch.filing_event.v1"
accession: "0001174947-25-000234"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2025-02-25T23:59:59+00:00"
generated_at: "2026-05-26T05:17:23.561884+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# CONMED appoints Mark Kaye as director; declares $0.20 quarterly dividend

## Summary
- Board expanded to nine; Mark Kaye appointed effective Feb 24, 2025, with Audit and Strategy committee assignments.
- Quarterly dividend of $0.20 per share declared, payable April 4, 2025 to holders of record March 14, 2025.
- Kaye currently EVP & CFO of Elevance Health; previously CFO of Moody's and senior finance roles at MassMutual and ING.
- Kaye received prorated equity grant of 152 RSUs and options on 1,846 shares, vesting in full on Feb 24, 2026.

## SEC filing metadata
- accession: 0001174947-25-000234
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2025-02-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000117494725000234/0001174947-25-000234-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000117494725000234/form8k-33666_cnmd.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001174947-25-000234
- JSON: https://secwatch.observer/filing/0001174947-25-000234.json
- Plain text: https://secwatch.observer/filing/0001174947-25-000234.txt

## Key facts
- Executive change
  Mark Kaye was appointed as Director at CONMED Corp.
  - Action: appointed
  - Role: Director
  source text: On February 24, 2025, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Mark Kaye as a director effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000117494725000234/0001174947-25-000234-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.